Subscribe To
sagimet biosciences to present at the h.c. wainwright 7th annual nash investor conference
SAN MATEO, Calif., Oct. 18, 2023 (GLOBE NEWSWIRE) -- sagimet Biosciences Inc. (Nasdaq: SGMT), a clinica...
October 18, 2023, 4:05 pm
sagimet biosciences announces completion of enrollment of 120 patients for phase 3 clinical trial by its partner ascletis of denifanstat combined with bevacizumab for treatment of recurrent glioblasto
SAN MATEO, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — sagimet Biosciences Inc. (Nasdaq: SGMT), a clini...
September 27, 2023, 8:05 pm
sagimet biosciences announces completion of enrollment of 120 patients for phase 3 clinical trial by its partner ascletis of denifanstat combined with bevacizumab for treatment of recurrent glioblasto
SAN MATEO, Calif., Sept. 27, 2023 (GLOBE NEWSWIRE) — sagimet Biosciences Inc. (Nasdaq: SGMT), a clini...
September 27, 2023, 8:05 pm
sagimet biosciences: recent ipo with emerging positive data in nash
sagimet Biosciences Inc. develops FASN inhibitors for diseases related to dysfunctional lipid metabolis...
September 27, 2023, 2:48 pm
U.s. ipo weekly recap: july ipo market kicks off with sizable biotechs
Following the Independence Day lull, the July IPO market warmed up with two sizable biotechs, joined by two blank check companies. Surf Air Mobility d...
July 15, 2023, 3:28 am
sagimet biosciences sets ipo terms, to raise up to about $80 million
sagimet Biosciences Inc. SGMT, disclosed Monday terms for its initial public offering, in which the Cal...
July 10, 2023, 7:05 am
Ipo report: sagimet biosciences gives going public a second chance under new ceo
Biotech drug developer sagimet Biosciences is taking another shot at going public, according to a filin...
June 23, 2023, 11:52 pm
: sagimet biosciences gives going public a second chance under new ceo
Biotech drug developer sagimet Biosciences is giving it another shot to take itself public, according t...
June 23, 2023, 9:59 pm